Analyst Ratings for Bicara Therapeutics Inc (BCAX)
BCAX Rating Summary
BCAX Price Target Summary
- Highest: $46.00 (Stifel)
- Lowest: $11.00 (Wells Fargo)
- Average: $31.17
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$31.17 (+34.2%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 84%
Rating Score: 8.1 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/10/2026 | Guggenheim | Brad Canino | New Coverage | Buy (N/A) |
42.00 (N/A) |
23.09 (23.23) |
0.61% | Details |
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
30.00 (N/A) |
21.47 (23.23) |
8.2% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
